{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:01:19Z","timestamp":1772136079721,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR10272\/BRB\/10\/1266\/2013"],"award-info":[{"award-number":["BT\/PR10272\/BRB\/10\/1266\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR10272\/BRB\/10\/1266\/2013"],"award-info":[{"award-number":["BT\/PR10272\/BRB\/10\/1266\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LS11-036\/2014(C)"],"award-info":[{"award-number":["SR\/FST\/LS11-036\/2014(C)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F.4.13\/2018\/DRS-III (SAP-II)"],"award-info":[{"award-number":["F.4.13\/2018\/DRS-III (SAP-II)"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aberrant activation of the PI3K\/AKT\/mTOR pathway is attributed to the pathogenesis of oral squamous cell carcinoma (OSCC). In recent years, increasing evidence suggests the involvement of microRNAs (miRNAs) in oral carcinogenesis by acting as tumor suppressors or oncogenes. TSC1, as a component of the above pathway, regulates several cellular functions such as cell proliferation, apoptosis, migration and invasion. Downregulation of TSC1 is reported in oral as well as several other cancers and is associated with an unfavourable clinical outcome in patients. Here we show that oncogenic miR-130a binds to the 3\u2032UTR of TSC1 and represses its expression. MiR-130a-mediated repression of TSC1 increases cell proliferation, anchorage independent growth and invasion of OSCC cells, which is dependent on the presence of the 3\u2032UTR in TSC1. We observe an inverse correlation between the expression levels of miR-130a and TSC1 in OSCC samples, suggesting that their interaction is physiologically relevant. Delivery of antagomiR-130a to OSCC cells results in a significant decrease in xenograft size. Taken together, the findings of the study indicate that miR-130a-mediated TSC1 downregulation is not only a novel mechanism in OSCC, but also the restoration of TSC1 levels by antagomiR-130a may be a potential therapeutic strategy for the treatment of OSCC.<\/jats:p>","DOI":"10.1038\/s41598-021-87388-4","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T06:13:19Z","timestamp":1617862399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oncogenic role of MiR-130a in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Karthik","family":"Mallela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swamy","family":"Shivananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodaganur S.","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"87388_CR1","first-page":"729","volume":"17","author":"S Islam","year":"2019","unstructured":"Islam, S., Abiko, Y., Uehara, O. & Chiba, I. Sirtuin 1 and oral cancer. Oncol. Lett. 17, 729\u2013738 (2019).","journal-title":"Oncol. Lett."},{"key":"87388_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2407-8-163","volume":"8","author":"S Chakraborty","year":"2008","unstructured":"Chakraborty, S., Mohiyuddin, S. M., Gopinath, K. S. & Kumar, A. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer 8, 163 (2008).","journal-title":"BMC Cancer"},{"key":"87388_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41241-017-0046-4","volume":"37","author":"DM Ferreira","year":"2017","unstructured":"Ferreira, D. M., Neves, T. J., Lima, L. G. C. A., Alves, F. A. & Begnami, M. D. Prognostic implications of the phosphatidylinositol 3-kinase\/Akt signaling pathway in oral squamous cell carcinoma: overexpression of p-mTOR indicates an adverse prognosis. Appl. Cancer Res. 37, 41 (2017).","journal-title":"Appl. Cancer Res."},{"key":"87388_CR4","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee, A. R. et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. PNAS USA 99, 13571\u201313576 (2002).","journal-title":"PNAS USA"},{"key":"87388_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47, 535\u2013546 (2012).","journal-title":"Mol. Cell"},{"key":"87388_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene on chromosome 9q34. Science 277, 805\u2013808 (1997).","journal-title":"Science"},{"key":"87388_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/hmg\/9.12.1721","volume":"9","author":"A Miloloza","year":"2000","unstructured":"Miloloza, A. et al. The TSC1 gene product hamartin negatively regulates cell proliferation. Hum. Mol. Genet. 9, 1721\u20131727 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"87388_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/35010550","volume":"2","author":"RF Lamb","year":"2000","unstructured":"Lamb, R. F. et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat. Cell Biol. 2, 281\u2013287 (2000).","journal-title":"Nat. Cell Biol."},{"key":"87388_CR9","doi-asserted-by":"publisher","first-page":"e54503","DOI":"10.1371\/journal.pone.0054503","volume":"8","author":"M Ohsawa","year":"2013","unstructured":"Ohsawa, M. et al. TSC1 controls distribution of actin fibers through its effect on function of Rho family of small GTPases and regulates cell migration and polarity. PLoS ONE 8, e54503 (2013).","journal-title":"PLoS ONE"},{"key":"87388_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nm.3097","volume":"19","author":"M Papadakis","year":"2013","unstructured":"Papadakis, M. et al. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat. Med. 19, 351\u2013357 (2013).","journal-title":"Nat. Med."},{"key":"87388_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2017.00160","volume":"10","author":"CY Li","year":"2017","unstructured":"Li, C. Y. et al. Downregulation of microRNA-193b-3p promotes autophagy and cell survival by targeting TSC1\/MTOR signaling in NSC-34 Cells. Front. Mol. Neurosci. 10, 160 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"87388_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"DF Lee","year":"2007","unstructured":"Lee, D. F. et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440\u2013455 (2007).","journal-title":"Cell"},{"key":"87388_CR13","doi-asserted-by":"publisher","first-page":"51372","DOI":"10.1074\/jbc.M303956200","volume":"278","author":"A Astrinidis","year":"2003","unstructured":"Astrinidis, A., Senapedis, W., Coleman, T. R. & Henske, E. P. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene by cyclin-dependent kinase 1\/cyclin B. J. Biol. Chem. 278, 51372\u201351379 (2003).","journal-title":"J. Biol. Chem."},{"key":"87388_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/hmg\/ddi444","volume":"15","author":"A Astrinidis","year":"2006","unstructured":"Astrinidis, A., Senapedis, W. & Henske, E. P. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Hum. Mol. Genet. 15, 287\u2013297 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"87388_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2015.01.026","volume":"32","author":"A Thien","year":"2015","unstructured":"Thien, A. et al. TSC1 activates TGF-\u03b2-Smad2\/3 signaling in growth arrest and Epithelial-to-Mesenchymal transition. Dev. Cell 32, 617\u2013630 (2015).","journal-title":"Dev. Cell"},{"key":"87388_CR16","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1073\/pnas.151033798","volume":"98","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi, T. et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to those caused by Tsc2 mutation in mice. PNAS USA 98, 8762\u20138767 (2001).","journal-title":"PNAS USA"},{"key":"87388_CR17","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1158\/0008-5472.CAN-10-1646","volume":"70","author":"RD Kladney","year":"2010","unstructured":"Kladney, R. D. et al. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Cancer Res. 70, 8937\u20138947 (2010).","journal-title":"Cancer Res."},{"key":"87388_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41598-017-00970-7","volume":"7","author":"HM Zhang","year":"2017","unstructured":"Zhang, H. M., Diaz, V., Walsh, M. E. & Zhang, Y. Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice. Sci. Rep. 7, 834 (2017).","journal-title":"Sci. Rep."},{"key":"87388_CR19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","volume":"41","author":"WG Jiang","year":"2005","unstructured":"Jiang, W. G. et al. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur. J. Cancer. 41, 1628\u20131636 (2005).","journal-title":"Eur. J. Cancer."},{"key":"87388_CR20","doi-asserted-by":"publisher","first-page":"27097","DOI":"10.18632\/oncotarget.4553","volume":"6","author":"HP Lin","year":"2015","unstructured":"Lin, H. P. et al. AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1\/TSC2. Oncotarget 6, 27097\u201327112 (2015).","journal-title":"Oncotarget"},{"key":"87388_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.4176","volume":"230","author":"Y Guo","year":"2013","unstructured":"Guo, Y. et al. TSC1 involvement in bladder cancer: diverse effects and therapeutic implications. J. Pathol. 230, 17\u201327 (2013).","journal-title":"J. Pathol."},{"key":"87388_CR22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/gutjnl-2016-312734","volume":"66","author":"DWH Ho","year":"2017","unstructured":"Ho, D. W. H. et al. TSC1\/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication. Gut 66, 1496\u20131506 (2017).","journal-title":"Gut"},{"key":"87388_CR23","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/onc.2009.452","volume":"29","author":"MC Liang","year":"2010","unstructured":"Liang, M. C. et al. TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Oncogene 29, 1588\u20131597 (2010).","journal-title":"Oncogene"},{"key":"87388_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/jso.23585","volume":"109","author":"SJ Byeon","year":"2014","unstructured":"Byeon, S. J., Han, N., Choi, J., Kim, M. A. & Kim, W. H. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma. J. Surg. Oncol. 109, 812\u2013817 (2014).","journal-title":"J. Surg. Oncol."},{"key":"87388_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1245\/s10434-014-3729-z","volume":"21","author":"SJ Lee","year":"2014","unstructured":"Lee, S. J. et al. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer. Ann. Surg. Oncol. 21, 634\u2013639 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"87388_CR26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3892\/or.2017.5811","volume":"38","author":"SC Tsai","year":"2017","unstructured":"Tsai, S. C. et al. The differential regulation of microRNAs is associated with oral cancer. Oncol. Rep. 38, 1613\u20131620 (2017).","journal-title":"Oncol. Rep."},{"key":"87388_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20, 460\u2013469 (2014).","journal-title":"Trends Mol. Med."},{"key":"87388_CR28","doi-asserted-by":"publisher","first-page":"14993","DOI":"10.18632\/oncotarget.3802","volume":"6","author":"J Du","year":"2015","unstructured":"Du, J. et al. MicroRNA-451 regulates stemness of side population cells via PI3K\/Akt\/mTOR signalling pathway in multiple myeloma. Oncotarget 6, 14993\u201315007 (2015).","journal-title":"Oncotarget"},{"key":"87388_CR29","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.18632\/oncotarget.23326","volume":"9","author":"G Liu","year":"2018","unstructured":"Liu, G. et al. MicroRNA-19a protects osteoblasts from dexamethasone via targeting TSC1. Oncotarget 9, 2017\u20132027 (2018).","journal-title":"Oncotarget"},{"key":"87388_CR30","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000494821","volume":"50","author":"N Wang","year":"2018","unstructured":"Wang, N., Liang, X., Yu, W., Zhou, S. & Fang, M. Differential expression of microRNA-19b promotes proliferation of cancer stem cells by regulating the TSC1\/mTOR signaling pathway in multiple myeloma. Cell Physiol. Biochem. 50, 1804\u20131814 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"87388_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11626-018-0292-0","volume":"54","author":"X Yuan","year":"2018","unstructured":"Yuan, X. et al. MiR-126-3p promotes the cell proliferation and inhibits the cell apoptosis by targeting TSC1 in the porcine granulosa cells. Vitro Cell Dev. Biol. Anim. 54, 715\u2013724 (2018).","journal-title":"Vitro Cell Dev. Biol. Anim."},{"key":"87388_CR32","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/s41418-018-0243-z","volume":"26","author":"J Lee","year":"2019","unstructured":"Lee, J., Heo, J. & Kang, H. MiR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia. Cell Death. Differ. 26, 1782\u20131795 (2019).","journal-title":"Cell Death. Differ."},{"key":"87388_CR33","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1038\/cdd.2017.129","volume":"24","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. MiR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-kappaB in high-grade serous ovarian carcinoma. Cell Death. Differ. 24, 2089\u20132100 (2017).","journal-title":"Cell Death. Differ."},{"key":"87388_CR34","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/or.2015.4099","volume":"34","author":"H Jiang","year":"2015","unstructured":"Jiang, H., Yu, W. W., Wang, L. L. & Peng, Y. MiR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol. Rep. 34, 1153\u20131161 (2015).","journal-title":"Oncol. Rep."},{"key":"87388_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41419-018-0966-2","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. The MYB\/miR-130a\/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma. Cell Death. Dis. 9, 917 (2018).","journal-title":"Cell Death. Dis."},{"key":"87388_CR36","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3892\/ol.2013.1251","volume":"5","author":"SG Liu","year":"2013","unstructured":"Liu, S. G. et al. Differential expression of miRNAs in esophageal cancer tissue. Oncol. Lett. 5, 1639\u20131642 (2013).","journal-title":"Oncol. Lett."},{"key":"87388_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1158\/1055-9965.EPI-18-0067","volume":"27","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 27, 746\u2013754 (2018).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"87388_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MAJ.0b013e3181e892a0","volume":"340","author":"XC Wang","year":"2010","unstructured":"Wang, X. C. et al. Expression of miRNA-130a in non small cell lung cancer. Am. J. Med. Sci. 340, 385\u2013388 (2010).","journal-title":"Am. J. Med. Sci."},{"key":"87388_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-4598-13-6","volume":"13","author":"YC Yen","year":"2014","unstructured":"Yen, Y. C. et al. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol. Cancer 13, 6 (2014).","journal-title":"Mol. Cancer"},{"key":"87388_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biopha.2015.02.011","volume":"71","author":"H Chi","year":"2015","unstructured":"Chi, H. MiR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling. Biomed. Pharmacother. 71, 53\u201357 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"87388_CR41","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","volume":"19","author":"G Benvenuto","year":"2000","unstructured":"Benvenuto, G. et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19, 6306 (2000).","journal-title":"Oncogene"},{"key":"87388_CR42","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1093\/nar\/gku278","volume":"42","author":"SA Pradhan","year":"2014","unstructured":"Pradhan, S. A., Rather, M. I., Tiwari, A., Bhat, V. K. & Kumar, A. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin. Nucleic Acids Res. 42, 6243\u20136255 (2014).","journal-title":"Nucleic Acids Res."},{"key":"87388_CR43","doi-asserted-by":"publisher","first-page":"33269","DOI":"10.18632\/oncotarget.5037","volume":"6","author":"SH Lee","year":"2015","unstructured":"Lee, S. H. et al. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget 6, 33269\u201333278 (2015).","journal-title":"Oncotarget"},{"key":"87388_CR44","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.2147\/OTT.S139443","volume":"10","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y., Li, R., Yu, H., Wang, R. & Shen, Z. MicroRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer. Onco. Targets Ther. 10, 3893\u20133905 (2017).","journal-title":"Onco. Targets Ther."},{"key":"87388_CR45","doi-asserted-by":"publisher","first-page":"e62589","DOI":"10.1371\/journal.pone.0062589","volume":"8","author":"Y Hashimoto","year":"2013","unstructured":"Hashimoto, Y., Akiyama, Y. & Yuasa, Y. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS ONE 8, e62589 (2013).","journal-title":"PLoS ONE"},{"key":"87388_CR46","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.ymthe.2018.07.023","volume":"26","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells. Mol. Ther. 26, 2466\u20132475 (2018).","journal-title":"Mol. Ther."},{"key":"87388_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2199-9-34","volume":"9","author":"S Sharbati-Tehrani","year":"2008","unstructured":"Sharbati-Tehrani, S., Kutz-Lohroff, B., Bergbauer, R., Scholven, J. & Einspanier, R. miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol. Biol. 9, 34 (2008).","journal-title":"BMC Mol. Biol."},{"key":"87388_CR48","doi-asserted-by":"publisher","first-page":"17621","DOI":"10.1038\/srep17621","volume":"5","author":"A Tiwari","year":"2015","unstructured":"Tiwari, A., Shivananda, S., Gopinath, K. S. & Kumar, A. Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivo. Sci. Rep. 5, 17621 (2015).","journal-title":"Sci. Rep."},{"key":"87388_CR49","doi-asserted-by":"publisher","first-page":"21865","DOI":"10.18632\/oncotarget.7990","volume":"7","author":"Q Zhao","year":"2016","unstructured":"Zhao, Q. et al. A direct quantification method for measuring plasma microRNAs identified potential biomarkers for detecting metastatic breast cancer. Oncotarget 7, 21865\u201321874 (2016).","journal-title":"Oncotarget"},{"key":"87388_CR50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.M112.425736","volume":"288","author":"MI Rather","year":"2013","unstructured":"Rather, M. I., Nagashri, M. N., Swamy, S. S., Gopinath, K. S. & Kumar, A. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J. Biol. Chem. 288, 608\u2013618 (2013).","journal-title":"J. Biol. Chem."},{"key":"87388_CR51","first-page":"2473","volume":"39","author":"S Jin","year":"2018","unstructured":"Jin, S., Wei, J., You, L., Liu, H. & Qian, W. Autophagy regulation and its dual role in blood cancers: a novel target for therapeutic development. Oncol. Rep. 39, 2473\u20132481 (2018).","journal-title":"Oncol. Rep."},{"key":"87388_CR52","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3389\/fimmu.2018.00966","volume":"9","author":"S Jung","year":"2018","unstructured":"Jung, S., G\u00e1mez-D\u00edaz, L., Proietti, M. & Grimbacher, B. \u201cImmune TOR-opathies,\u201d a novel disease entity in clinical immunology. Front. Immunol. 9, 966 (2018).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87388-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:34:47Z","timestamp":1670031287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87388"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87388-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-130377\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7787"}}